Several retrospective clinical studies in ovarian cancer have also demonstrated that intratumoral VEGF and VEGFR-2 expression and VEGF gene polymorphisms are independent poor prognostic factors [27–29]. The gene discussed is VEGFA; the disease is ovarian carcinoma.